Development and Validation of a Simplified Method for Analysis of SARS-CoV-2 RNA in University Dormitories

被引:9
作者
Strike, William [1 ]
Amirsoleimani, Atena [2 ]
Olaleye, Abisola [2 ]
Noble, Ann [2 ]
Lewis, Kevin [3 ]
Faulkner, Lee [3 ]
Backus, Spencer [2 ]
Lindeman, Sierra [2 ]
Eterovich, Katrina [2 ]
Fraley, Melicity [2 ]
Banadaki, Mohammad Dehghan [2 ]
Torabi, Soroosh [2 ]
Rockward, Alexus [1 ]
Zeitlow, Eli [4 ]
Liversedge, Matthew [5 ]
Keck, James [5 ]
Berry, Scott [1 ,6 ]
机构
[1] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40506 USA
[2] Univ Kentucky, Mech Engn, Lexington, KY 40506 USA
[3] Univ Kentucky, Environm Qual Management, Lexington, KY 40508 USA
[4] Univ Wisconsin, Dept Mech Engn, Platteville, WI 53818 USA
[5] Univ Kentucky, Family & Community Med, Lexington, KY 40504 USA
[6] Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA
来源
ACS ES&T WATER | 2022年
基金
美国国家卫生研究院;
关键词
COVID-19; wastewater; assays; nucleic acids; epidemiology; PURIFICATION; INTEGRATION;
D O I
10.1021/acsestwater.2c00044
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Over the course of the COVID-19 pandemic, wastewater surveillance has become a useful tool for describing SARS-CoV-2 prevalence in populations of varying size, from individual facilities (e.g., university residence halls, nursing homes, prisons) to entire municipalities. Wastewater analysis for SARS-CoV-2 RNA requires specialized equipment, expensive consumables, and expert staff, limiting its feasibility and scalability. Further, the extremely labile nature of viral RNA complicates sample transportation, especially in regions with limited access to reliable cold chains. Here, we present a new method for wastewater analysis, termed exclusion-based sample preparation (ESP), that substantially simplifies workflow (at least 70% decrease in time; 40% decrease in consumable usage compared with traditional techniques) by targeting the labor-intensive processing steps of RNA purification and concentration. To optimize and validate this method, we analyzed wastewater samples from residence halls at the University of Kentucky, of which 34% (44/129) contained detectible SARS-CoV-2 RNA. Although concurrent clinical testing was not comprehensive, student infections were identified in the 7 days following a positive wastewater detection in 68% of samples. This pilot study among university residence halls validated the performance and utility of the ESP method, laying the foundation for future studies in regions of the world where wastewater testing is not currently feasible.
引用
收藏
页码:1984 / 1991
页数:8
相关论文
共 50 条
  • [41] Epidemiology of SARS-CoV-2
    Salzberger, Bernd
    Buder, Felix
    Lampl, Benedikt
    Ehrenstein, Boris
    Hitzenbichler, Florian
    Holzmann, Thomas
    Schmidt, Barbara
    Hanses, Frank
    INFECTION, 2021, 49 (02) : 233 - 239
  • [42] Epidemiology of SARS-CoV-2
    Bernd Salzberger
    Felix Buder
    Benedikt Lampl
    Boris Ehrenstein
    Florian Hitzenbichler
    Thomas Holzmann
    Barbara Schmidt
    Frank Hanses
    Infection, 2021, 49 : 233 - 239
  • [43] Method versatility in RNA extraction-free PCR detection of SARS-CoV-2 in saliva samples
    Allicock, Orchid M.
    Yolda-Carr, Devyn
    Earnest, Rebecca
    Breban, Mallery I.
    Vega, Noel
    Ott, Isabel M.
    Kalinich, Chaney
    Alpert, Tara
    Petrone, Mary E.
    Wyllie, Anne L.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2023, 182 : 103 - 108
  • [44] Detection of SARS-CoV-2 RNA with a Simple Concentration Method in Wastewater in Turkey: A Pilot Study in Corum
    Aydogdu, Sabiha
    Karasartova, Djursun
    Savci, Unsal
    Gureser, Ayse Semra
    Arslan Akveran, Gonul
    Akti, Merve
    Gurel, Busra
    Kocaman, Cagdas
    Acar, Aytac
    Kosar, Nezahat
    Xiao, Lihua
    Taylan Ozkan, Aysegul
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 620 - 627
  • [45] Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis
    Shaikh, Aisha
    Zeldis, Etti
    Campbell, Kirk N.
    Chan, Lili
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (02): : 290 - 292
  • [46] Technical considerations to development of serological tests for SARS-CoV-2
    Ernst, Emilie
    Wolfe, Patricia
    Stahura, Corrine
    Edwards, Katie A.
    TALANTA, 2021, 224
  • [47] SARS-CoV-2 virus: Vaccines in development
    Huang, Qingrui
    Yan, Jinghua
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 131 - 138
  • [48] Development of vaccines against SARS-CoV-2
    Leon-Lara, Ximena
    Otero-Mendoza, Francisco
    ACTA PEDIATRICA DE MEXICO, 2020, 41 (04): : S23 - S26
  • [49] Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats
    Stranieri, Angelica
    Lauzi, Stefania
    Giordano, Alessia
    Galimberti, Luigi
    Ratti, Gabriele
    Decaro, Nicola
    Brioschi, Federica
    Lelli, Davide
    Gabba, Silvia
    Amarachi, Ndiana Linda
    Lorusso, Eleonora
    Moreno, Ana
    Trogu, Tiziana
    Paltrinieri, Saverio
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (04) : 2089 - 2095
  • [50] Development and implementation of an operational concept in a university eye hospital in the SARS-CoV-2 pandemic
    Singh, Pankaj
    Mueller, Michael
    Hack, Daniel
    Kempf, Volkhard A. J.
    Wicker, Sabine
    Koenig, Clara
    Mueller-Kassner, Annika
    Lindner, Katja
    Deters, Tobias
    Graf, Juergen
    Kohnen, Thomas
    OPHTHALMOLOGE, 2020, 117 (07): : 595 - 601